Association of HLA mismatching with clinical outcome. Risks of mortality (A), grades III to IV acute GVHD (B), and relapse (C) associated with one HLA-A, HLA-B, HLA-C, or HLA-DRB1 mismatch relative to one HLA-DQB1 mismatch among patients with TT, MT, and MM leader genotypes.